VOLUME
61 2000 NUMBER 10
Brainstorms
710 The New Cholinesterase Inhibitors
for Alzheimer's Disease, Part 1: Their Similarities Are
Different. Stephen M. Stahl
[PDF]
Original Articles
712 How Fast Are Antidepressants?
Alan J. Gelenberg and Chelsea L. Chesen
[Abstract]
[PDF]
722 Efficacy, Adverse Events, and
Treatment Discontinuations in Fluoxetine Clinical Studies of
Major Depression: A Meta-Analysis of the 20-mg/day Dose.Charles
M. Beasley, Jr., Mary E. Nilsson, Stephanie C. Koke, and Jill S.
Gonzales
[Abstract]
[PDF]
729 Prodromal Symptoms of Relapse in a
Sample of Egyptian Schizophrenic Patients. Ahmed Okasha,
Zeinab Bishry, Mohamed Rifaat El Fiki, Aida Seif El Dawla, and
Amany Haroun El Rasheed
[Abstract]
[PDF]
737 Restlessness of Respiration as a
Manifestation of Akathisia: Five Case Reports of Respiratory
Akathisia. Shigehiro Hirose
[Abstract]
[PDF]
742 Elevated Levels of Insulin, Leptin,
and Blood Lipids in Olanzapine-Treated Patients With
Schizophrenia or Related Psychoses. Kristina I. Melkersson,
Anna-Lena Hulting, and Kerstin E. Brismar
[Abstract]
[PDF]
750 Treatment of Depression With
Methylphenidate in Patients Difficult to Wean From Mechanical
Ventilation in the Intensive Care Unit. Hans-Bernd
Rothenhausler, Sigrid Ehrentraut, Georges von Degenfeld, Michael
Weis, Monika Tichy, Erich Kilger, Christian Stoll, Gustav
Schelling, and Hans-Peter Kapfhammer
[Abstract]
[PDF]
756 Genetic Studies of Panic Disorder: A
Review. Odile A. van den Heuvel, Ben J. M. van de Wetering,
Dick J. Veltman, and David L. Pauls
[Abstract]
[PDF]
767 An Algorithm for the Treatment of
Schizophrenia in the Correctional Setting: The Forensic Algorithm
Project. Charles A. Buscema, Qamar A. Abbasi, David J. Barry,
and Timothy H. Lauve
[Abstract]
[PDF]
Academic Highlights
791 Alzheimer's Disease: Translating
Neurochemical Insights Into Clinical Benefits.
[PDF]
CME Article 803
804 Diagnosing Bipolar Disorder and the
Effect of Antidepressants: A Naturalistic Study. S. Nassir
Ghaemi, Erica E. Boiman, and Frederick K. Goodwin
[Abstract]
[PDF]
Letters to the Editor
784 EMDR for Treatment of PTSD. -Gary
Peterson -Nancy J. Smyth, Ricky Greenwald, Ad de Jongh,
and Christopher Lee
[PDF]
- Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances
785 Further Discussion of EMDR for
Treatment of PTSD. Charles R. Figley, Andrew M. Leeds, Sandra
A. TinkerWilson, and Bessel A. van der Kolk
[PDF]
- Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances
786 Omission of Bupropion as a
Recommended Treatment for PTSD. Ralph M. Reeves
[PDF]
- Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances
787 Psychodynamic Psychotherapy for
PTSD. -Jose A. Saporta-Eric M. Plakun and Edward R. Shapiro
[PDF]
- Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances
Book Reviews 789
Information for authors
see July 2000, pages 542544 or our Web
site at www.psychiatrist.com/author.htm